Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations

被引:17
|
作者
Vardhan, Seshu [1 ]
Sahoo, Suban K. [1 ]
机构
[1] Sardar Vallabhbhai Natl Inst Technol SVNIT, Dept Chem, Surat 395007, Gujarat, India
来源
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE | 2022年 / 12卷 / 01期
关键词
COVID-19; Limonoids; Triterpenoids; Molecular docking; Dynamics simulation; ACUTE RESPIRATORY SYNDROME; INHIBITORS; PROTEIN; ENDORIBONUCLEASE; REPLICATION; HELICASES; ACID;
D O I
10.1016/j.jtcme.2021.12.002
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background and aim: The ongoing global pandemic due to SARS-CoV-2 caused a medical emergency. Since December 2019, the COVID-19 disease is spread across the globe through physical contact and respiratory droplets. Coronavirus caused a severe effect on the human immune system where some of the non-structural proteins (nsp) are involved in virus-mediated immune response and pathogenesis. To suppress the viral RNA replication mechanism and immune-mediated responses, we aimed to identify limonoids and triterpenoids as antagonists by targeting helicases (nsp13), exonuclease (nsp14), and endoribonuclease (nsp15) of SARS-CoV-2 as therapeutic proteins. Experimental procedure: In silico molecular docking and drug-likeness of a library of 369 phytochemicals from limonoids and triterpenoids were performed to screen the potential hits that binds effectively at the active site of the proteins target. In addition, the molecular dynamics simulations of the proteins and their complexes with the potential hits were performed for 100 ns by using GROMACS. Results and conclusion: The potential compounds 26-deoxyactein and 25-O-anhydrocimigenol 3-O-beta-D-xylopyranoside posing strong interactions with a minimum binding energy of -10.1 and -9.5 kcal/mol, respectively and sustained close contact with nsp13 for 100 ns. The nsp14 replication fork activity was hindered by the tomentosolic acid, timosaponin A-I, and shizukaol A with the binding affinity score of -9.2, -9.2, and -9.0 kcal/mol, respectively. The nsp15 endoribonuclease catalytic residues were inhibited potentially by limonin, 25-O-anhydrocimigenol 3-O-alpha-L-arabinopyranoside, and asperagenin posing strong binding affinity scores of -9.0, -8.8, and -8.7 kcal/mol, respectively. Computationally predicted potential phytochemicals for SARS-CoV-2 are known to possess various medicinal properties. (C) 2021 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC.
引用
收藏
页码:44 / 54
页数:11
相关论文
共 50 条
  • [41] Structural Studies of Non-structural protein 15 (Nsp15) Endoribonuclease from Original SARS-CoV-2 and its Variant Epsilon for Therapeutic Intervention
    Sonowal, Manashi
    Nagaratnam, Nirupa
    Logeswaran, Dhenugen
    Jernigen, Rebecca
    Fromme, Raimund
    Fromme, Petra
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2023, 79 : A315 - A315
  • [42] Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10
    Zhao, Huilin
    Liu, Jin
    He, Lei
    Zhang, Lichuan
    Yu, Rilei
    Kang, Congmin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 626 : 114 - 120
  • [43] In-silicoscreening of plant-derived antivirals against main protease, 3CLproand endoribonuclease, NSP15 proteins of SARS-CoV-2
    Sharma, Aniket
    Goyal, Shubham
    Yadav, Arvind Kumar
    Kumar, Pawan
    Gupta, Lovely
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (01): : 86 - 100
  • [44] Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19
    Selvaraj, Chandrabose
    Dinesh, Dhurvas Chandrasekaran
    Panwar, Umesh
    Abhirami, Rajaram
    Boura, Evzen
    Singh, Sanjeev Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (13): : 4582 - 4593
  • [45] Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach
    Olaa Motwalli
    Meshari Alazmi
    Journal of Molecular Modeling, 2021, 27
  • [46] Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach
    Motwalli, Olaa
    Alazmi, Meshari
    JOURNAL OF MOLECULAR MODELING, 2021, 27 (06)
  • [47] Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach
    Romeo, Isabella
    Ambrosio, Francesca Alessandra
    Costa, Giosue
    Corona, Angela
    Alkhatib, Mohammad
    Salpini, Romina
    Lemme, Saverio
    Vergni, Davide
    Svicher, Valentina
    Santoro, Maria Mercedes
    Tramontano, Enzo
    Ceccherini-Silberstein, Francesca
    Artese, Anna
    Alcaro, Stefano
    MOLECULES, 2022, 27 (21):
  • [48] Inhibition of SARS-CoV-2 NSP-15 by Uridine-5′-Monophosphate Analogues Using QSAR Modelling, Molecular Dynamics Simulations, and Free Energy Landscape
    Alshahrani, Mohammed Merae
    SAUDI PHARMACEUTICAL JOURNAL, 2024, 32 (01)
  • [49] Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: anin silicoassisted drug-repurposing study
    Khan, Rameez Jabeer
    Jha, Rajat Kumar
    Singh, Ekampreet
    Jain, Monika
    Amera, Gizachew Muluneh
    Singh, Rashmi Prabha
    Muthukumaran, Jayaraman
    Singh, Amit Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (01): : 438 - 448
  • [50] Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes
    Sharma, Anshika
    Ong, Joe W.
    Loke, Mun Fai
    Chua, Eng Guan
    Lee, Joseph J.
    Choi, Hyung Won
    Tan, Yee Joo
    Lal, Sunil K.
    Chow, Vincent T.
    MICROORGANISMS, 2021, 9 (06)